Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Kenergy Scientific, Inc.Financial_Report.xls

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________

Amendment No. 1 to

FORM 10-Q

 

S     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2013

 

£     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File No. 333-120507

 

KENERGY SCIENTIFIC, INC.

(Exact name of the Registrant)

 

New Jersey 20-1862816
(State of Incorporation) (I.R.S. Employer ID Number)

 

30 Eglinton Ave W, Suite 808, Mississauga, Ontario, Canada, M5H 2W9
(Address of Principal Executive Offices) (Zip Code)

 

866-520-2370

(Registrant’s Telephone No. including Area Code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  S   No  £

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes  £ No  S

 

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Act).   Yes  £  No S

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer £ Accelerated filer £ Non-accelerated filer £ Smaller reporting company S
    (Do not check if a smaller reporting company)  

 

 

Indicate the number of shares outstanding of the issuer's common stock, as of the latest practical date:

 

62,270 shares outstanding of Preferred Stock, par value $1.00 per share; 5,217,475,719 shares outstanding of Class A Common Stock, no par value and 10,000 shares outstanding of Class B Common Stock, par value $.01 per share, as of September 1, 2013.

 

 

 

 
 

 

 

EXPLANATORY NOTE

 

 

This Amendment No. 1 to the Quarterly Report on Form 10-Q is being filed solely to furnish the Interactive Data files as Exhibit 101, in accordance with Rule 405 of Regulation S-T. No other changes have been made to the Form 10-Q, as originally filed on September 17, 2013.

 

 

 

 

 

 
 

 

 

PART II - OTHER INFORMATION

 

 

Item 6.       Exhibits

 

 

101.INS   XBRL Instances Document*
101.SCH   XBRL Taxonomy Extension Schema Document*
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB   XBRL Taxonomy Extension Label Linkbase Document*
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document *

 ______________

 

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are not deemed filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act or Section 18 of the Securities Exchange Act and otherwise not subject to liability

 

 

 

 

1
 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant caused this amendment to report on Form 10-Q to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Kenergy Scientific, Inc. September 19, 2013
   
By:     /s/ Zoran Cvetojevic  
               Zoran Cvetojevic  
               Interim Chief Executive Officer  

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:     /s/ Zoran Cvetojevic September 19, 2013
               Zoran Cvetojevic  
               Interim Chief Executive Officer  

 

 

2